Clearside Biomedical Inc (CLSD)
1.31
-0.01
(-0.76%)
USD |
NASDAQ |
May 03, 16:00
1.32
+0.01
(+0.76%)
After-Hours: 20:00
Clearside Biomedical Cash and Short Term Investments (Quarterly): 28.92M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 28.92M |
September 30, 2023 | 28.80M |
June 30, 2023 | 35.00M |
March 31, 2023 | 41.42M |
December 31, 2022 | 48.26M |
September 30, 2022 | 53.38M |
June 30, 2022 | 29.03M |
March 31, 2022 | 34.37M |
December 31, 2021 | 30.44M |
September 30, 2021 | 25.22M |
June 30, 2021 | 26.41M |
March 31, 2021 | 26.15M |
December 31, 2020 | 17.29M |
September 30, 2020 | 14.84M |
June 30, 2020 | 15.07M |
March 31, 2020 | 20.93M |
December 31, 2019 | 22.60M |
September 30, 2019 | 22.55M |
Date | Value |
---|---|
June 30, 2019 | 26.17M |
March 31, 2019 | 34.94M |
December 31, 2018 | 40.88M |
September 30, 2018 | 64.94M |
June 30, 2018 | 84.43M |
March 31, 2018 | 101.06M |
December 31, 2017 | 37.64M |
September 30, 2017 | 52.63M |
June 30, 2017 | 66.04M |
March 31, 2017 | 77.45M |
December 31, 2016 | 83.63M |
September 30, 2016 | 56.92M |
June 30, 2016 | 55.28M |
March 31, 2016 | 15.89M |
December 31, 2015 | 20.28M |
September 30, 2015 | 4.186M |
December 31, 2014 | 8.269M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
14.84M
Minimum
Sep 2020
53.38M
Maximum
Sep 2022
28.78M
Average
26.41M
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
Cassava Sciences Inc | 121.14M |
Heron Therapeutics Inc | 80.41M |
Actinium Pharmaceuticals Inc | 84.06M |
Karyopharm Therapeutics Inc | 191.44M |
Ocular Therapeutix Inc | 195.81M |